Literature DB >> 12014648

Roles of thymidylate synthase and dihydropyrimidine dehydrogenase in tumor progression and sensitivity to 5-fluorouracil in human gastric cancer.

M Terashima1, T Irinoda, H Fujiwara, T Nakaya, A Takagane, K Abe, H Yonezawa, K Oyama, T Inaba, K Saito, T Takechi, M Fukushima.   

Abstract

BACKGROUND: The role of thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD) enzyme activities in tumor progression and sensitivity to 5-fluorouracil (5-FU) were evaluated.
MATERIALS AND METHODS: TS and DPD activities were measured in 81 clinical samples of gastric cancer. TS and DPD activities were determined by 5-fluorodeoxyuridine monophosphate binding assay and by radioenzymatic assay, respectively. Sensitivity to 5-FU was determined by in vitro ATP assay.
RESULTS: There was no correlation between TS activity and sensitivity to 5-FU. However, a weak correlation was found between DPD activity and sensitivity to 5-FU. In a subgroup of patients who did not receive adjuvant chemotherapy, overall survival was poorer in patients with high TS activity (p=0.0265). Conversely, in a subgroup of patients who received 5-FU-based adjuvant chemotherapy, overall survival was poorer in patients with high DPD activity (p=0.0465).
CONCLUSION: These results suggest that TS has an important role in tumor progression and DPD may be the dominant predictor of 5-FU sensitivity in gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12014648

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  13 in total

Review 1.  Prediction of clinical outcome of fluoropyrimidine-based chemotherapy for gastric cancer patients, in terms of the 5-fluorouracil metabolic pathway.

Authors:  Wataru Ichikawa
Journal:  Gastric Cancer       Date:  2006       Impact factor: 7.370

2.  Relative level of thymidylate synthase mRNA expression in primary tumors and normal tissues predicts survival of patients with oral tongue squamous cell carcinoma.

Authors:  Ryuji Yasumatsu; Torahiko Nakashima; Takahiro Wakasaki; Toranoshin Ayada; Hideki Kadota; Muneyuki Masuda; Satoshi Toh; Hideki Shiratsuchi; Shizuo Komune
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-08-21       Impact factor: 2.503

3.  Prediction of sensitivity to fluoropyrimidines by metabolic and target enzyme activities in gastric cancer.

Authors:  Masanori Terashima; Hisataka Fujiwara; Akinori Takagane; Kaoru Abe; Takashi Irinoda; Tsutomu Nakaya; Hitoshi Yonezawa; Kenichi Oyama; Kazuyoshi Saito; Norio Kanzaki; Satoshi Ohtani; Tsuyoshi Nemoto; Yutaka Hoshino; Michihiko Kogure; Mitsukazu Gotoh
Journal:  Gastric Cancer       Date:  2003       Impact factor: 7.370

4.  Screening of lymph nodes metastasis associated lncRNAs in colorectal cancer patients.

Authors:  Jun Han; Long-Fei Rong; Chuan-Bin Shi; Xiao-Gang Dong; Jie Wang; Bao-Lin Wang; Hao Wen; Zhen-Yu He
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

5.  Thymidylate synthetase and dihydropyrimidine dehydrogenase mRNA levels in esophageal cancer.

Authors:  Masahiro Kimura; Yoshiyuki Kuwabara; Akira Mitsui; Hideyuki Ishiguro; Nobuyoshi Sugito; Tatsuya Tanaka; Midori Shiozaki; Yasuhiro Naganawa; Hiromitsu Takeyama
Journal:  Oncol Lett       Date:  2010-12-16       Impact factor: 2.967

Review 6.  The Impact of the Expression Level of Intratumoral Dihydropyrimidine Dehydrogenase on Chemotherapy Sensitivity and Survival of Patients in Gastric Cancer: A Meta-Analysis.

Authors:  Cong Zhang; Hongpeng Liu; Bin Ma; Yongxi Song; Peng Gao; Yingying Xu; Dehao Yu; Zhenning Wang
Journal:  Dis Markers       Date:  2017-01-31       Impact factor: 3.434

7.  Quantitative measurement of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level in gastric cancer by real-time RT-PCR.

Authors:  Hisataka Fujiwara; Masanori Terashima; Takashi Irinoda; Akinori Takagane; Kaoru Abe; Masahiro Kashiwaba; Kennichi Oyama; Masanori Takahashi; Chihaya Maesawa; Kazuyoshi Saito; Teiji Takechi; Masakazu Fukushima
Journal:  Jpn J Cancer Res       Date:  2002-12

8.  Expression of ERCC1 and TYMS in colorectal cancer patients and the predictive value of chemotherapy efficacy.

Authors:  Hong Jiang; Baosong Li; Fengxia Wang; Chong Ma; Tao Hao
Journal:  Oncol Lett       Date:  2019-05-23       Impact factor: 2.967

9.  Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival.

Authors:  J-S Kim; M-A Kim; T M Kim; S-H Lee; D-W Kim; S-A Im; T-Y Kim; W H Kim; H-K Yang; D S Heo; Y-J Bang; K-U Lee; K-J Choe; N K Kim
Journal:  Br J Cancer       Date:  2009-03-10       Impact factor: 7.640

10.  Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer.

Authors:  J Matsubara; T Nishina; Y Yamada; T Moriwaki; T Shimoda; T Kajiwara; T E Nakajima; K Kato; T Hamaguchi; Y Shimada; Y Okayama; T Oka; K Shirao
Journal:  Br J Cancer       Date:  2008-01-29       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.